|
Report No. : |
345548 |
|
Report Date : |
17.10.2015 |
IDENTIFICATION DETAILS
|
Name : |
PEHACHEVE S.A |
|
|
|
|
Registered Office : |
273,
Boulevard Jean Jacques Dessalines Port-au-Prince |
|
|
|
|
Country : |
Haiti |
|
|
|
|
Date of Incorporation : |
01.01.1960 |
|
|
|
|
Com. Reg. No.: |
NIF
000-023-289-9 |
|
|
|
|
Legal Form : |
Public
Company |
|
|
|
|
Line of Business : |
Subject is is involved
in pharmaceutical and chemical products as a distributor and wholesaler. |
|
|
|
|
No. of Employee : |
100 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Haiti |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
STATUTORY INFORMATION
|
|
|
|
|
|
Legal Name: |
PEHACHEVE S.A |
|
Trade Name: |
PEHACHEVE |
|
Registration Number: |
NIF 000-023-289-9 |
|
Date Created: |
1960 |
|
Date Incorporated: |
01-01-60 |
|
Legal Address: |
273, Boulevard Jean Jacques Dessalines
Port-au-Prince, Haiti |
|
Operative Address: |
110 Rue Des Miracles |
|
Port-Au-Prince, , Haiti |
|
|
Telephone: |
509 3776-7922 |
|
Fax: |
509 2510-7371 |
|
Legal Form: |
Public Company |
|
Email: |
|
|
Registered in: |
Haiti |
|
Website: |
No website |
|
Contact: |
Carlos Boulos, Director |
|
Staff: |
100 |
|
Activity: |
Chemical Wholesalers Industry |
|
|
|
BANKS
Central Bank of Haiti The company does not make its banking data public |
|
|
|
|
|
|
|
HISTORY
|
|
|
|
|
|
The
company started business in 1960. |
|
|
|
|
PRINCIPAL ACTIVITY
|
|
|
|
The company is involved in pharmaceutical and chemical
products as a distributor and wholesaler. |
|
Products/Services description: |
Pharmaceutical products |
|
Sales are: |
Wholesale |
|
Clients: |
Client: |
|
Ministère de la Santé Publique
et de la Population (MSPP) |
|
|
Client Type: |
|
|
National |
|
|
Client Sector: |
|
|
Government |
|
|
Goods Provided to Client: |
|
|
Sales of drugs (Vente de
médicaments) |
|
|
Client: |
|
|
L'Armée du Salut |
|
|
Client Type: |
|
|
National |
|
|
Goods Provided to Client: |
|
|
Sales of drugs (Vente de
médicaments) |
|
|
Client: |
|
|
L'Hôpital de l'Université
d'Etat d'Haiti (HUEH) |
|
|
Client Type: |
|
|
National |
|
|
Client Sector: |
|
|
Government |
|
|
Goods Provided to Client: |
|
|
Sales of drugs (Vente de
médicaments) |
|
|
Brands: |
Masculan® |
|
Suppliers: |
CHINA ORNATE LAMIPACK PVT., LTD. |
|
China |
|
|
|
|
|
Twilight Litaka Pharma Ltd. |
|
|
India |
|
|
|
|
|
PURE PHARMA U CHEMIKALIEN |
|
|
China |
|
|
|
|
|
BTP PHARMACEUTICAL CO LIMITED |
|
|
China |
|
|
|
|
|
Zeon Health Industries On |
|
|
UK |
|
|
|
|
|
Pangea Chemicals Pvt. Ltd. |
|
|
India |
|
|
|
|
|
Alkem Laboratories Ltd. |
|
|
India |
|
|
Operations area: |
National |
|
The company imports from |
France, Germany, India, United States, China |
|
The company exports to |
No exports |
|
The subject employs |
100 employees |
|
Payments: |
Slow but correct |
|
|
|
|
|
|
LOCATION
|
|
|
Headquarters : |
110 Rue Des Miracles |
|
Port-Au-Prince, , Haiti |
|
|
Branches: |
The company does not have branches |
|
Industry: |
Companies in this industry manufacture and process
pharmaceutical products. |
|
|
|
|
Demand for pharmaceuticals is driven by the desire
to cure illness and disease. The profitability of individual companies
depends on their ability to discover and market new drugs. Large companies
benefit from their economies of scale in research, manufacturing, and
marketing. Small companies can compete effectively by specializing in drugs
that target one or two specific ailments and by partnering with larger
drugmakers. |
|
|
|
|
|
Drugs are chemicals with beneficial biological activity.
Modern drug development is an outgrowth of recent research into the specific
causes of illness and disease, coupled with advances in chemistry and
industrial technology that allow scientists to manufacture chemicals to
improve these conditions. |
|
|
|
|
|
|
|
GROUP STRUCTURE
AND SUBSIDIARY COMPANIES
|
|
|
Listed at the stock exchange: |
NO |
|
Capital: |
NA |
|
Shareholders %: |
This is a private company. The owner is Carlo
BOULOS. |
|
Management: |
Carlos Boulos, Director |
|
Patrick Boulos, Director
General |
|
|
Related Companies: |
No subsidiary companies |
|
|
|
|
|
|
FINANCIAL INFORMATION
|
|
|
|
This is a private company which does not make its
financial statements public. |
|
|
|
|
|
There are no financial connected to the subject. |
|
|
|
LEGAL FILINGS
|
|
|
|
|
|
|
There are no legal filings registered for the
subject |
|
|
|
SUMMARY
|
|
|
|
|
|
|
PEHACHEVE is a company located in Haiti, dedicated
to the import and wholesale of pharmaceutical products. |
|
|
|
|
The company has a large sized structure and 55 years
of experience in the market. |
|
|
|
|
|
It is active and shows no negative,mainly importing
from India and China. |
|
|
|
|
|
However, Haiti’s current economic situation is
critical. We suggest a low credit line. |
|
|
|
|
RISK INFORMATION
|
|
|
|
|
|
DEBTS |
Controlled |
|
PAYMENTS |
Regular |
|
CASH FLOW |
Normal |
|
SUGGESTED CREDIT LINE |
USD 10 000 |
|
STATUS |
Active |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.39 |
|
|
1 |
Rs.91.05 |
|
Euro |
1 |
Rs.66.16 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.